Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Viruses|August 28, 2025
A Replication-Defective Myxoma Virus Inducing Pro-Inflammatory Responses as Monotherapy and an Adjuvant to Chemo- and DC Immuno-Therapy for Ovarian CancerMartin J Cannon, Jia LiuExpert Opinion on Biological Therapy|May 22, 2009
Cellular immunotherapy for ovarian cancerMartin J Cannon, Timothy J O'BrienFrontiers in Immunology|December 5, 2013
Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancerHannah E Goyne, Martin J CannonImmunotherapy|September 6, 2012
The case for HER2/neu as a therapeutic target for gynecologic malignanciesHannah E Goyne, Martin J CannonMOJ Immunology|January 15, 2019
Regulatory T Cells in Gynecologic CancerYang Ou, Martin J Cannon, Mayumi NakagawaJournal of Virology|April 29, 2005
Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polioRahnuma Wahid, Martin J Cannon, Marie ChowJournal of Virology|December 15, 2004
Dendritic cells and macrophages are productively infected by poliovirusRahnuma Wahid, Martin J Cannon, Marie ChowVaccines|September 8, 2015
Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated MacrophagesMartin J Cannon, Debopam Ghosh, Swetha GujjaInternational Reviews of Immunology|May 12, 2011
Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?Maurizio Chiriva-Internati, Everardo Cobos, Martin J CannonNature Reviews. Microbiology|February 3, 2005
Endemic Burkitt's lymphoma: a polymicrobial disease?Rosemary Rochford, Martin J Cannon, Ann M MoormannPageof 6